<prof_article_slide_presentation>
    <front_label>Front Matter</front_label>
    <above_title/>
    <title>
        <p>The Big Debate: Pharmacologic vs Alternative Approaches in Smoking Cessation</p>
    </title>
    <contrbtr_pre_content>
        <p>WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.</p>
    </contrbtr_pre_content>
    <contrbtr_byline>
        <p>Henri-Jean Aubin, MD, PhD; Peter Hajek, PhD; Philip Toennesen, MD, DMSc; Serena Tonstad, MD, PhD</p>
    </contrbtr_byline>
    <contrbtr_group>
        <contrbtr_type_lbl>Authors</contrbtr_type_lbl>
        <contrbtr_element chronicleid="0901c79180b0d2c7">
            <contrbtr_nm>Henri-Jean Aubin, MD, PhD</contrbtr_nm>
            <contrbtr_title>
                <p>Professor
                    <br/>University Paris-Sud
                    <br/>Director of the Addiction Science Research Group in the INSERM 1018 Unit
                    <br/>Villejuif, France
                </p>
            </contrbtr_title>
            <contrbtr_bio/>
            <contrbtr_disclsr>
                <p>Disclosure: Henri-Jean Aubin, MD, PhD, has disclosed the following relevant financial relationships:
                    <br/>Served as an advisor or consultant for: D&amp;A Pharma; Ethypharm; Lundbeck, Inc.; Pfizer Inc.
                    <br/>Served as a speaker or a member of a speakers bureau for: Lundbeck, Inc.; Merck &amp; Co., Inc.;
                    <br/>Novartis Pharmaceuticals Corporation; Pierre Fabre Sante; Pfizer Inc.
                </p>
            </contrbtr_disclsr>
        </contrbtr_element>
        <contrbtr_element chronicleid="0901c79180dd4f44">
            <contrbtr_nm>Peter Hajek, PhD</contrbtr_nm>
            <contrbtr_title>
                <p>Professor of Clinical Psychology
                    <br/>Queen Mary University of London
                    <br/>London, United Kingdom
                </p>
            </contrbtr_title>
            <contrbtr_bio/>
            <contrbtr_disclsr>
                <p>Disclosure: Peter Hajek, PhD, has disclosed the following relevant financial relationships:
                    <br/>Served as an advisor or consultant for: Pfizer Inc
                </p>
            </contrbtr_disclsr>
        </contrbtr_element>
        <contrbtr_element chronicleid="0901c79180dd4f45">
            <contrbtr_nm>Philip Toennesen, MD, DMSc</contrbtr_nm>
            <contrbtr_title>
                <p>Senior Consultant, Specialist in Pulmonary Medicine
                    <br/>Expert in Sleep Disorders and Smoking Cessation
                    <br/>Department of Sleep Disorders
                    <br/>Rigshospitalet
                    <br/>Copenhagen, Denmark
                </p>
            </contrbtr_title>
            <contrbtr_bio/>
            <contrbtr_disclsr>
                <p>Disclosure: Philip Toennesen, MD, DMSc, has disclosed the following relevant financial relationships:
                    <br/>Served as an advisor or consultant for: Fertim Pharma; Pfizer Inc.
                    <br/>Served as a speaker or a member of a speakers bureau for: Fertim Pharma; Pfizer Inc.
                </p>
            </contrbtr_disclsr>
        </contrbtr_element>
        <contrbtr_element chronicleid="0901c79180d2b3b3">
            <contrbtr_nm>Serena Tonstad, MD, PhD</contrbtr_nm>
            <contrbtr_title>
                <p>Professor
                    <br/>Loma Linda University
                    <br/>Loma Linda, California, United States
                    <br/>Head Physician
                    <br/>Oslo University Hospital
                    <br/>Oslo, Norway
                </p>
            </contrbtr_title>
            <contrbtr_bio/>
            <contrbtr_disclsr>
                <p>Disclosure: Serena Tonstad, MD, PhD, has disclosed the following relevant financial relationships:  
                    <br/>
                    Served as an advisor or consultant for: Pfizer Inc. 
                    <br/>
                    Served as a speaker or a member of a speakers bureau for: Pfizer Inc.
                </p>
            </contrbtr_disclsr>
        </contrbtr_element>
    </contrbtr_group>
    <contrbtr_group>
        <contrbtr_type_lbl>Editor</contrbtr_type_lbl>
        <contrbtr_element>
            <contrbtr_nm>Wilma Guerra, BA, ELS</contrbtr_nm>
            <contrbtr_title>
                <p>Scientific Director, WebMD Global, LLC</p>
            </contrbtr_title>
            <contrbtr_bio/>
            <contrbtr_disclsr>
                <p>Disclosure: Wilma Guerra, BA, ELS, has disclosed no relevant financial relationships.</p>
            </contrbtr_disclsr>
        </contrbtr_element>
    </contrbtr_group>
    <contrbtr_group>
        <contrbtr_type_lbl>Content Reviewer</contrbtr_type_lbl>
        <contrbtr_element>
            <contrbtr_nm>Esther Nyarko, PharmD</contrbtr_nm>
            <contrbtr_title>
                <p>Associate CME Clinical Director</p>
            </contrbtr_title>
            <contrbtr_bio/>
            <contrbtr_disclsr>
                <p>Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.</p>
            </contrbtr_disclsr>
        </contrbtr_element>
    </contrbtr_group>
    <contrbtr_bulk_info/>
    <contrbtr_post_content/>
    <supprtr_grant_group>
        <supprtr_grant_attr>/webmd/professional_assets/medscape/images/grant_attribution/pfizer-ieg-img-2018.gif</supprtr_grant_attr>
    </supprtr_grant_group>
    <body_label>Body</body_label>
    <toc_element>
        <TOCLabel/>
        <toc_type>Default</toc_type>
        <sec_element>
            <sec_header/>
            <subsec_element>
                <subsec_header/>
                <slide_intro/>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide1.png</sec_img>
                    <sec_label>Slide 1.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Program Introduction</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 1.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide2.png</sec_img>
                    <sec_label>Slide 2.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Program Agenda</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 2.</sec_alt_txt>
                    <qna_form>3</qna_form>
                </slide_grp>
            </subsec_element>
            <subsec_element>
                <subsec_header/>
                <slide_intro/>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide3.png</sec_img>
                    <sec_label>Slide 3.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>The Importance of a Complete Quit</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 3.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide4.png</sec_img>
                    <sec_label>Slide 4.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Worldwide Leading Causes of Attributable Global Mortality
                            <sup type="ref">[1]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 4.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide5.png</sec_img>
                    <sec_label>Slide 5.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Smoking Leads to an 11-Year Loss of Life Span
                            <sup type="ref">[2]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 5.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide6.png</sec_img>
                    <sec_label>Slide 6.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Mortality and Morbidity Rates Associated With Smoking 
                            <sup type="ref">[2,3]</sup>
                        </h3>
                        <ul>
                            <li>The figure on the left shows that there is a monotonous dose effect relationship between cigarettes per day and all-cause mortality</li>
                            <li>This means that even low smoking rates are associated with an increased risk of mortality</li>
                            <li>In the specific case of cardiovascular disease, most of the mortality risk is borne by low smoking rates, as seen in the curve on the right</li>
                        </ul>
                    </sec_txt>
                    <sec_alt_txt>Slide 6.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide7.png</sec_img>
                    <sec_label>Slide 7.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Mortality and Morbidity Rates Associated With Smoking (cont)
                            <sup type="ref">[2,4]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 7.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide8.png</sec_img>
                    <sec_label>Slide 8.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>All-Cause Mortality Risk Reduction After Quitting Smoking
                            <sup type="ref">[5]</sup>
                        </h3>
                        <ul>
                            <li>It is believed that complete quit is the safest and most effective way to reduce the all-cause mortality associated with smoking</li>
                            <li>It is also believed that the reduction of all-cause mortality stabilizes roughly 10 to 15 years after complete smoking cessation</li>
                        </ul>
                    </sec_txt>
                    <sec_alt_txt>Slide 8.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide9.png</sec_img>
                    <sec_label>Slide 9.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Little Evidence of All-Cause Mortality Risk Reduction After Smoking Reduction
                            <sup type="ref">[6-9]</sup>
                        </h3>
                        <ul>
                            <li>It is important to keep in mind that in all the studies shown on this slide, smoking reduction was not supported by any nicotine replacement use</li>
                            <li>Moreover, it is known that reduction of cigarettes per day does not reflect reduction of toxin exposure</li>
                        </ul>
                    </sec_txt>
                    <sec_alt_txt>Slide 9.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide10.png</sec_img>
                    <sec_label>Slide 10.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Harm Reduction Concept: People Who Do Not Want to Give Up Tobacco or Nicotine Use Completely
                            <sup type="ref">[10]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 10.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide11.png</sec_img>
                    <sec_label>Slide 11.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Cigarette Smoking Causes the Most Harm
                            <sup type="ref">[11]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 11.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide12.png</sec_img>
                    <sec_label>Slide 12.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Conclusions</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 12.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide13.png</sec_img>
                    <sec_label>Slide 13.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Pharmacologic Therapies for Smoking Cessation: The Evidence</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 13.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide14.png</sec_img>
                    <sec_label>Slide 14.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Nicotine Replacement Therapy vs Control for Smoking Cessation
                            <sup type="ref">[12]</sup>
                        </h3>
                        <ul>
                            <li>Nicotine replacement therapy is the oldest, most established, and most used therapy for smoking cessation</li>
                            <li>Based on the results of this analysis, the Cochrane Group collaborators stated that they will never do another meta-analysis of this type, because the evidence is so strong for nicotine replacement against placebo
    
                                <ul>
                                    <li>Subgroup and other types of analyses may be conducted, for example, comparing nicotine replacement with e-cigarettes or other comparators, but the placebo comparison is firmly established at this time</li>
                                </ul>
                            </li>
                        </ul>
                    </sec_txt>
                    <sec_alt_txt>Slide 14.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide15.png</sec_img>
                    <sec_label>Slide 15.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>First-Line Drugs in Smoking Cessation: Meta-Analysis of Cochrane Register Efficacy Data
                            <sup type="ref">[12-15]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 15.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide16.png</sec_img>
                    <sec_label>Slide 16.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Efficacy of Varenicline: Phase 3 and 4 Studies (Weeks 9-12)
                            <sup type="ref">[16-25]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 16.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide17.png</sec_img>
                    <sec_label>Slide 17.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Efficacy of Varenicline: Phase 3 and 4 Studies (Weeks 9-52)
                            <sup type="ref">[16,17,21-23,25]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 17.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide18.png</sec_img>
                    <sec_label>Slide 18.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Quit Rates Flexible Quit Date Study
                            <sup type="ref">[24]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 18.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide19.png</sec_img>
                    <sec_label>Slide 19.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Varenicline Maintenance Study
                            <sup type="ref">[26]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 19.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide20.png</sec_img>
                    <sec_label>Slide 20.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Maintenance Treatment With Varenicline in Patients With Schizophrenia and Bipolar Disorder
                            <sup type="ref">[27]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 20.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide21.png</sec_img>
                    <sec_label>Slide 21.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>EAGLES: Continuous Abstinence Rates in Psychiatric and Nonpsychiatric Cohorts
                            <sup type="ref">[28]</sup>
                        </h3>
                        <ul>
                            <li>This is the EAGLES study and included over 8000 subjects, both people with psychiatric disease and people without known psychiatric disease</li>
                            <li>The study was sponsored by both producers of varenicline and of bupropion and in collaboration with health authorities</li>
                        </ul>
                    </sec_txt>
                    <sec_alt_txt>Slide 21.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide22.png</sec_img>
                    <sec_label>Slide 22.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Primary Endpoint for the EAGLES Study: Nonpsychiatric Adverse Events
                            <sup type="ref">[28]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 22.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide23.png</sec_img>
                    <sec_label>Slide 23.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Tolerability and Safety Issues
                            <sup type="ref">[29]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 23.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide24.png</sec_img>
                    <sec_label>Slide 24.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Physician Perspectives
                            <sup type="ref">[30]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 24.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide25.png</sec_img>
                    <sec_label>Slide 25.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Lack of Readiness to Use Pharmacologic Options (Smoker)</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 25.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide26.png</sec_img>
                    <sec_label>Slide 26.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>E-Cigarettes and "Heat-Not-Burn" Devices</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 26.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide27.png</sec_img>
                    <sec_label>Slide 27.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Current Controversy</h3>
                        <ul>
                            <li>In my opinion, what we see in our field is this split in the attitude to e-cigarettes, which I believe is based on priority</li>
                            <li>If the priority is smoke-related death and disease, then there is a sort of pragmatic perspective in which alternative lower-risk nicotine devices may appear as promising to lower the total of death and disease from smoking</li>
                            <li>By contrast, the other view is the concern that providing nicotine in the less dangerous form still maintains and may even increase nicotine use in the population
    
                                <ul>
                                    <li>Hence, safe nicotine devices are both a problem and a risk</li>
                                </ul>
                            </li>
                        </ul>
                    </sec_txt>
                    <sec_alt_txt>Slide 27.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide28.png</sec_img>
                    <sec_label>Slide 28.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Recent UK Reports Regarding the Use of E-Cigarettes
                            <sup type="ref">[31-33]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 28.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide29.png</sec_img>
                    <sec_label>Slide 29.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Conclusions of UK Reviews</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 29.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide30.png</sec_img>
                    <sec_label>Slide 30.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>The Opposite View</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 30.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide31.png</sec_img>
                    <sec_label>Slide 31.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Time Will Tell</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 31.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide32.png</sec_img>
                    <sec_label>Slide 32.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>UK Experience So Far</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 32.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide33.png</sec_img>
                    <sec_label>Slide 33.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>"Heat-Not-Burn" Products
                            <sup type="ref">[34]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 33.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide34.png</sec_img>
                    <sec_label>Slide 34.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Cigarette Sales Decline: Japan, 2014-2018</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 34.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide35.png</sec_img>
                    <sec_label>Slide 35.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>The DUO Study
                            <sup type="ref">[35]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 35.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide36.png</sec_img>
                    <sec_label>Slide 36.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Background
                            <sup type="ref">[35]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 36.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide37.png</sec_img>
                    <sec_label>Slide 37.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>DUO Study
                            <sup type="ref">[35]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 37.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide38.png</sec_img>
                    <sec_label>Slide 38.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Study Procedures
                            <sup type="ref">[35]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 38.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide39.png</sec_img>
                    <sec_label>Slide 39.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Are Dual Users Interested in Varenicline?
                            <sup type="ref">[35]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 39.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide40.png</sec_img>
                    <sec_label>Slide 40.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Did Those Wanting and Not Wanting Varenicline Differ?
                            <sup type="ref">[35]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 40.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide41.png</sec_img>
                    <sec_label>Slide 41.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Quitting Outcomes
                            <sup type="ref">[35]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 41.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide42.png</sec_img>
                    <sec_label>Slide 42.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Quitting Vaping, Smoking, and Both
                            <sup type="ref">[35]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 42.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide43.png</sec_img>
                    <sec_label>Slide 43.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Changes in Enjoyment of Smoking and Vaping
                            <sup type="ref">[35]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 43.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide44.png</sec_img>
                    <sec_label>Slide 44.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Conclusions
                            <sup type="ref">[35]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 44.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide45.png</sec_img>
                    <sec_label>Slide 45.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>What Do the Guidelines Say?</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 45.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide46.png</sec_img>
                    <sec_label>Slide 46.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>WHO Framework Convention on Tobacco Control
                            <sup type="ref">[36]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 46.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide47.png</sec_img>
                    <sec_label>Slide 47.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>WHO Urges Restrictions on E-Cigarettes (2016)
                            <sup type="ref">[37]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 47.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide48.png</sec_img>
                    <sec_label>Slide 48.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Interventions to Reduce Harm From Continued Tobacco Use
                            <sup type="ref">[10]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 48.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide49.png</sec_img>
                    <sec_label>Slide 49.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>NICE 2018: 1.5 Advice on E-Cigarettes for Health and Social Care Workers in Primary and Community Settings
                            <sup type="ref">[38]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 49.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide50.png</sec_img>
                    <sec_label>Slide 50.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Clinical Guidelines for General Practice
                            <sup type="ref">[39]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 50.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide51.png</sec_img>
                    <sec_label>Slide 51.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Clinical Guidelines for General Practice (cont)
                            <sup type="ref">[39]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 51.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide52.png</sec_img>
                    <sec_label>Slide 52.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Clinical Guidelines for General Practice (cont)
                            <sup type="ref">[39]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 52.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide53.png</sec_img>
                    <sec_label>Slide 53.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Canadian Smoking Cessation Guideline Summary Statement
                            <sup type="ref">[40]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 53.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide54.png</sec_img>
                    <sec_label>Slide 54.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Canadian Smoking Cessation Guideline Summary Statement (cont)
                            <sup type="ref">[40]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 54.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide55.png</sec_img>
                    <sec_label>Slide 55.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Canadian Smoking Cessation Guideline Summary Statement (cont)
                            <sup type="ref">[40]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 55.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide56.png</sec_img>
                    <sec_label>Slide 56.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Medical Societies</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 56.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide57.png</sec_img>
                    <sec_label>Slide 57.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>AHA Smoking Guidelines 2014</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 57.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide58.png</sec_img>
                    <sec_label>Slide 58.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Position Statement of the Forum of International Respiratory Societies: E-Cigarettes
                            <sup type="ref">[41]</sup>
                        </h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 58.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide59.png</sec_img>
                    <sec_label>Slide 59.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Conlusions</h3>
                    </sec_txt>
                    <sec_alt_txt>Slide 59.</sec_alt_txt>
                    <qna_form>4</qna_form>
                </slide_grp>
            </subsec_element>
            <subsec_element>
                <subsec_header/>
                <slide_intro/>
                <slide_grp>
                    <sec_img>/webmd/professional_assets/medscape/images/content/article/903/975/Slide60.png</sec_img>
                    <sec_label>Slide 60.</sec_label>
                    <sec_caption/>
                    <sec_txt>
                        <h3>Thank You</h3>
                        <p></p>
                        <p></p>
                        <p>
                            <em>This content has been condensed for improved clarity.</em>
                        </p>
                    </sec_txt>
                    <sec_alt_txt>Slide 60.</sec_alt_txt>
                    <qna_form/>
                </slide_grp>
            </subsec_element>
        </sec_element>
        <pg_footnotes/>
    </toc_element>
    <toc_element>
        <toc_label>
            <p>Abbreviations</p>
        </toc_label>
        <toc_type>Sidebar</toc_type>
        <sec_element>
            <sec_header>
                <p>Abbreviations</p>
            </sec_header>
            <subsec_element>
                <subsec_header/>
                <slide_intro>
                    <p>AE = adverse event
                        <br/>Af = Africa
                        <br/>AHA = American Heart Association
                        <br/>CI = confidence interval
                        <br/>COPD = chronic obstructive pulmonary disease
                        <br/>CVD = cardiovascular disease
                        <br/>EC = e-cigarettes
                        <br/>FDA = US Food and Drug Administration
                        <br/>FTND = Fagerström Test for Nicotine Dependence
                        <br/>HR = hazard ratio
                        <br/>HTN = hypertension
                        <br/>Hx = history
                        <br/>LatAm = Latin America
                        <br/>MDD = major depressive disorder
                        <br/>ME = Middle East
                        <br/>MI = myocardial infarction
                        <br/>NHS = National Health Service
                        <br/>NRT = nicotine replacement therapy
                        <br/>NS = not significant
                        <br/>OTC = over the counter
                        <br/>PRN = as needed
                        <br/>RR = relative risk
                        <br/>Rx = prescription
                        <br/>SRNT = Society for Research on Nicotine and Tobacco
                        <br/>SR = sustained release
                        <br/>TQD = target quit date
                        <br/>WHO = World Health Organization
                    </p>
                </slide_intro>
            </subsec_element>
        </sec_element>
        <pg_footnotes/>
    </toc_element>
    <toc_element>
        <toc_label>
            <p>Q &amp; A</p>
        </toc_label>
        <toc_type>Sidebar</toc_type>
        <sec_element>
            <sec_header>
                <p>Q &amp; A</p>
            </sec_header>
            <subsec_element>
                <subsec_header/>
                <slide_intro>
                    <div class="app-loading">
                        <div class="webcomp-player" data-config="en/pi/editorial/studio/configs/2018/education/903975/903975_3.json" data-playertype="edu" id="cme-video-player"></div>
                    </div>
                </slide_intro>
            </subsec_element>
        </sec_element>
        <pg_footnotes/>
    </toc_element>
    <toc_element>
        <toc_label/>
        <toc_type>References</toc_type>
        <sec_element>
            <sec_header/>
            <subsec_element>
                <subsec_header/>
                <slide_intro>
                    <ol>
                        <li>Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. 
                            <em>Lancet. </em>2012;380:2224-2260.
                        </li>
                        <li>Pirie K, Peto R, Reeves GK, et al. The 21st century hazard of smoking and benefits of stopping: a prospective study of one million women in the UK. 
                            <em>Lancet. </em>2013;381:133-141.
                        </li>
                        <li>Morris PB, Ference BA, Jahangir E, et al. Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: clinical perspectives from the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. 
                            <em>J Am Coll Cardiol</em>. 2015;66:1378-1391.
                        </li>
                        <li>Hackshaw A, Morris JK, Boniface S, et al. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. 
                            <em>BMJ</em>. 2018;360:j5855.
                        </li>
                        <li>Hu Y, Zong G, Liu G, et al. Smoking cessation, weight change, type 2 diabetes, and mortality. 
                            <em>N Engl J Med. </em>2018;379:623-632.
                        </li>
                        <li>Godtfredsen NS, Holst C, Prescott E, et al. Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19.372 men and women from The Copenhagen Centre for Prospective Population Studies. 
                            <em>Am J Epidemiol. </em>2002;156:994-1001.
                        </li>
                        <li>Tverdal A, Bjartveit K. Health consequences of reduced dailt cigarette consumption. 
                            <em>Tobacco Control. </em>2006;15:472-480.
                        </li>
                        <li>Gerber Y, Myers V, Goldbourt U. Smoking reduction at midlife and lifetime mortality risk in men: a prospective cohort study. 
                            <em>Am J Epidemiol. </em>2012;175:1006-1012.
                        </li>
                        <li>Hart C, Gruer L, Bauld L. Does smoking reduction in midlife reduce mortality risk? Results of 2 long-term prospective cohort studies of men and women in Scotland. 
                            <em>Am J Epidemiol. </em>2013;178:770-779.
                        </li>
                        <li>Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, et al. Interventions to reduce harm from continued tobacco use. 
                            <em>Cochrane Database Syst Rev. </em>2016;10:Cd005231.
                        </li>
                        <li>Abrams DB, Glasser AM, Pearson JL, et al. Harm minimization and tobacco control: reframing societal views of nicotine use to rapidly save lives. 
                            <em>Annu Rev Public Health. </em>2018;39:193-213.
                        </li>
                        <li>Hartmann-Boyce J, Chepkin SC, Ye W, et al. Nicotine replacement therapy versus control for smoking cessation (review). 
                            <em>Cochrane Database Sys Rev. </em>2018;5:CD000146.
                        </li>
                        <li>Cahill K, Stevens S, Perera R, et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. 
                            <em>Cochrane Database Syst Rev. </em>2013;4:CD006103.
                        </li>
                        <li>Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. 
                            <em>Cochrane Database Syst Rev. </em>2012;4.
                        </li>
                        <li>Cahill K, Lindson-Hawley N, Thomas KH, et al. Nicotine receptor partial agonists for smoking cessation. 
                            <em>Cochrane Database Syst Rev. </em>2016;5:CD006103
                        </li>
                        <li>Gonzales D, Rennard SI, Nides M, et al; for the Varenicline Phase 3 Study Group. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. 
                            <em>JAMA</em>. 2006;296:47-55.
                        </li>
                        <li>Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. 
                            <em>JAMA</em>. 2006;296:56-63.
                        </li>
                        <li>Tsai ST, Cho HJ, Cheng HS, et al. A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. 
                            <em>Clin Ther.</em> 2007;29:1027-1039.
                        </li>
                        <li>Wang C, Xiao D, Chan KP, et al. Varenicline for smoking cessation: a placebo-controlled, randomized study. 
                            <em>Respirology</em> 2009;14:384-392.
                        </li>
                        <li>Bolliger CT, Issa JS, Posadas-Valay R, et al. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study. 
                            <em>Clin Ther. </em>2011;33:465-477.
                        </li>
                        <li>Rigotti NA, Pipe AL, Benowitz NL, et al. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. 
                            <em>Circulation. </em>2010; 121:221-229.
                        </li>
                        <li>Tashkin DP, Rennard S, Hays JT, et al. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. 
                            <em>Chest.</em> 2011;139:591-599.
                        </li>
                        <li>Anthenelli RM, Morris C, Ramey TS, et al. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. 
                            <em>Ann Int Med</em> 2013;159:390-400.
                        </li>
                        <li>Rennard S, Hughes J, Cinciripini PM, et al; Flexible Quit Date Study Group. A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates. 
                            <em>Nic Tob Research</em> 2012;14:343-350.
                        </li>
                        <li>Gonzales D, Hajek P, Pliamm L, et al. Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial. 
                            <em>Clin Pharm Therap.</em> 2014;96:390-396.
                        </li>
                        <li>Tonstad S, Tønnesen P, Hajek P, et al; Varenicline Phase 3 Study Group. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. 
                            <em>JAMA. </em>2006;296:64-71.
                        </li>
                        <li>Evins E, Cather C, Pratt SA. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized, clinical trial. 
                            <em>JAMA. </em>2014;311:145-154.
                        </li>
                        <li>Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. 
                            <em>Lancet. </em>2016;387:2507-2520.
                        </li>
                        <li>Barboza JL, Patel R, Patel P, et al. An update on the pharmacotherapeutic interventions for smoking cessation. 
                            <em>Expert Opin Pharmacother. </em>2016;17:1483-1496.
                        </li>
                        <li>Bartsch AL, Härter M, Niedrich J, et al. A systematic literature review of self-reported smoking cessation counseling by primary care physicians. 
                            <em>PLoS One. </em>2016;11:e0168482.
                        </li>
                        <li>Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. April 2016. https://www.rcplondon.ac.uk/file/3563/download?token=Mu0K_ZR0. Accessed October 12, 2018.</li>
                        <li>McNeill A, Brose LS, Calder R, et al. E-cigarettes: an evidence update. A report commissioned by Public Health England. 2015. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/733022/Ecigarettes_an_evidence_update_A_report_commissioned_by_Public_Health_England_FINAL.pdf. Accessed October 12, 2018.</li>
                        <li>McNeill A, Brose LS, Calder R, et al. Evidence review of e-cigarettes and heated tobacco products 2018. A report commissioned by Public Health England. 2018. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/684963/Evidence_review_of_e-cigarettes_and_heated_tobacco_products_2018.pdf. Accessed October 12, 2018.</li>
                        <li>Japan Tobacco Inc. Japanese Domestic Cigarette Sales Results for July 2018. August 17, 2018. https://www.jt.com/media/news/2018/pdf/20180817_02.pdf. Accessed October 12, 2018.</li>
                        <li>Hajek P, Peerbux S, Philips-Waller A, et al. Interest in using varenicline and its effects in people who both smoke and vape. Poster presented at: Society for Research on Nicotine and Tobacco Europe 18
                            <sup>th</sup> Annual Conference; September 6-8, 2018; Munich, Germany. Med-1.
                        </li>
                        <li>World Health Organization. 
                            <em>WHO Framework Convention on Tobacco Control.</em> Geneva, Switzerland; World Health Organization; 2003.
                        </li>
                        <li>Gulland A, et al. WHO urges restrictions on e-cigarettes. 
                            <em>BMJ </em>2016;355:i5991.
                        </li>
                        <li>National Institute for Health Care Excellence. Stop smoking interventions and services. NICE guideline NG92. March 28, 2018. nice.org.uk/guidance/ng92. Accessed October 12, 2018.</li>
                        <li>Verbiest M, Brakema E, van der Kleij R, et al. National guidelines for smoking cessation in primary care: a literature review and evidence analysis. 
                            <em>NPJ Prim Care Respir Med. </em>2017;27:2
                        </li>
                        <li>Canadian Action Network for the Advancement, Dissemination and Adoption of Practice-informed Tobacco Treatment (CAN-ADAPTT). Canadian Smoking Cessation Clinical Practice Guideline. 2011. https://www.peelregion.ca/health/professionals/events/pdf/2013/canadaptt-summary-statements.pdf. Accessed October 12, 2018.</li>
                        <li>Schraufnagel DE, Blasi F, Drummond MB, et al; Forum of International Respiratory Societies. Electronic cigarettes. A position statement of the forum of international respiratory societies. 
                            <em>Am J Respir Crit Care Med. </em>2014;190:611-618.
                        </li>
                    </ol>
                </slide_intro>
            </subsec_element>
        </sec_element>
        <pg_footnotes/>
    </toc_element>
    <back_label>Back Matter</back_label>
    <ref_grp>
        <ref_item/>
    </ref_grp>
    <cpyrt_holder>
        <p>WebMD Global, LLC</p>
        <script type="text/javascript">var pfizFlag = "active";</script>
    </cpyrt_holder>
    <cpyrt_ovrd/>
    <disclmr_ovrd/>
    <bkmtr_front>
        <p>
            <strong>Disclaimer</strong>
        </p>
        <p>The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.</p>
        <p>The material presented here does not necessarily reflect the views of WebMD Global, LLC or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the European Medicines Agency for use in Europe and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.</p>
    </bkmtr_front>
    <bkmtr_glossary/>
    <bkmtr_ack/>
    <bkmtr_discl/>
    <bkmtr_funding/>
    <bkmtr_reprnt_addr/>
    <bkmtr_abbr_notes/>
    <bkmtr_last/>
    <img_ttl_bkgrd/>
    <img_publ_logo/>
</prof_article_slide_presentation>
